Alice Blue Home
URL copied to clipboard

Trending News

Eiko Lifesciences jumps 11% after getting nod to acquire 51% stake in SSM Formulation

Eiko LifeSciences acquires 51% stake in SSM Formulations and approves raising funds through warrants and equity shares, subject to regulatory and shareholder approvals at upcoming EGM.
Eiko Lifesciences rises 7% after receiving approval to acquire a 51% stake in SSM Formulation

Introduction

Leading pharmaceutical company acquires majority stake in another firm and approves raising funds through warrants and equity shares, subject to regulatory and shareholder approvals at upcoming extraordinary general meeting.

Alice Blue Image

Also Read: SEPC Ltd settles issues with Hindustan Copper, receives new order

Share price movement of Eiko LifeSciences

On December 11, 2025, Eiko Lifesciences Ltd opened at ₹53.71, up 1.01% from its previous close of ₹53.18. The stock reached a high of ₹59.00 (10.97%) and a low of ₹53.18 (-0.00%). By 3:27 PM, it traded at ₹55.38, a 4.14% increase, with a market cap of ₹75.99 crore.

Eiko LifeSciences Approves Acquisition

Eiko LifeSciences Limited announced the acquisition of 51% equity in SSM Formulations, making it a subsidiary. The decision was approved by the Board during its meeting on December 11, 2025.

The Board approved raising funds through up to 33 lakh warrants, convertible into equity shares at ₹55 each, aggregating up to ₹18.15 crore, subject to regulatory and shareholder approvals at EGM.

Additionally, Eiko LifeSciences approved issuing up to 6.75 lakh equity shares at ₹55 each, aggregating ₹3.71 crore. The EGM will be held January 7, 2026, via VC/OAVM for member approvals.

Stock performance of Eiko LifeSciences for Period of 1 week, 6 months, and 1 year

Eiko Lifesciences Ltd delivered a 4.75% return over the past week, a 4.91% gain over the past six months, and a -11.4% decline over the past year.

Alice Blue Image

Also Read: Dilip Buildcon gains after ₹5,000 Cr NALCO contract for 25 years

Shareholding pattern of Eiko LifeSciences

ParticularsSep 2025Jun 2025Mar 2025
Promoter37%37%36%
FII0.00%0.00%0.00%
DII0.00%0.00%0.00%
Public63%63%64%

About Eiko LifeSciences

Eiko Lifesciences Ltd (BSE: 540204) manufactures, processes, and sells specialty and fine chemicals, including organic, inorganic chemicals, and pharmaceutical intermediates, serving domestic and international markets since its incorporation in 2021.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Eiko Lifesciences Ltd share price going up today?

A: Eiko Lifesciences Ltd share price is rising after acquiring 51% equity in SSM Formulations, approved by the Board on December 11, 2025.

Q: What does Eiko Lifesciences Ltd specialize in?

A: Eiko Lifesciences Ltd specializes in manufacturing, processing, and selling specialty and fine chemicals, including organic, inorganic, and pharmaceutical intermediates.

Q: What is the market capitalization of Eiko Lifesciences Ltd?

A: Eiko Lifesciences Ltd has a market capitalization of ₹75.99 crore as of December 11, 2025.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News
गिफ्ट निफ्टी लाइव टुडे अक्टूबर 12: कच्चे तेल की कीमतों में गिरावट से बाजार में तेजी के संकेत
Global Market

गिफ्ट निफ्टी लाइव टुडे अक्टूबर 12: कच्चे तेल की कीमतों में गिरावट से बाजार में तेजी के संकेत

मेटा डिस्क्रिप्शन: गिफ्ट निफ्टी लाइव टुडे अक्टूबर 12 के संकेतों से भारतीय बाजारों में सकारात्मक शुरुआत की उम्मीद है। कच्चे

*T&C apply